We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Lung Cancer

Journal Scan / Consensus and Guidelines · August 04, 2022

Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
J. Clin. Oncol 2022 Jul 11;[EPub Ahead of Print], N Singh, S Temin, S Baker, E Blanchard, JR Brahmer, P Celano, N Duma, PM Ellis, IB Elkins, RY Haddad, PJ Hesketh, D Jain, DH Johnson, NB Leighl, H Mamdani, G Masters, PR Moffitt, T Phillips, GJ Riely, AG Robinson, R Rosell, JH Schiller, BJ Schneider, DR Spigel, IA Jaiyesimi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading